Literature DB >> 27100892

A cardiac mitochondrial cAMP signaling pathway regulates calcium accumulation, permeability transition and cell death.

Z Wang1, D Liu1, A Varin1, V Nicolas2, D Courilleau2, P Mateo1, C Caubere3, P Rouet3, A-M Gomez1, G Vandecasteele1, R Fischmeister1,2, C Brenner1,2.   

Abstract

Although cardiac cytosolic cyclic 3',5'-adenosine monophosphate (cAMP) regulates multiple processes, such as beating, contractility, metabolism and apoptosis, little is known yet on the role of this second messenger within cardiac mitochondria. Using cellular and subcellular approaches, we demonstrate here the local expression of several actors of cAMP signaling within cardiac mitochondria, namely a truncated form of soluble AC (sACt) and the exchange protein directly activated by cAMP 1 (Epac1), and show a protective role for sACt against cell death, apoptosis as well as necrosis in primary cardiomyocytes. Upon stimulation with bicarbonate (HCO3(-)) and Ca(2+), sACt produces cAMP, which in turn stimulates oxygen consumption, increases the mitochondrial membrane potential (ΔΨm) and ATP production. cAMP is rate limiting for matrix Ca(2+) entry via Epac1 and the mitochondrial calcium uniporter and, as a consequence, prevents mitochondrial permeability transition (MPT). The mitochondrial cAMP effects involve neither protein kinase A, Epac2 nor the mitochondrial Na(+)/Ca(2+) exchanger. In addition, in mitochondria isolated from failing rat hearts, stimulation of the mitochondrial cAMP pathway by HCO3(-) rescued the sensitization of mitochondria to Ca(2+)-induced MPT. Thus, our study identifies a link between mitochondrial cAMP, mitochondrial metabolism and cell death in the heart, which is independent of cytosolic cAMP signaling. Our results might have implications for therapeutic prevention of cell death in cardiac pathologies.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27100892      PMCID: PMC4855650          DOI: 10.1038/cddis.2016.106

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  60 in total

Review 1.  Mitochondria as the central control point of apoptosis.

Authors:  S Desagher; J C Martinou
Journal:  Trends Cell Biol       Date:  2000-09       Impact factor: 20.808

Review 2.  Experimental radiation-induced heart disease: past, present, and future.

Authors:  Marjan Boerma
Journal:  Radiat Res       Date:  2012-06-04       Impact factor: 2.841

Review 3.  Programmed necrosis, not apoptosis, in the heart.

Authors:  Gloria Kung; Klitos Konstantinidis; Richard N Kitsis
Journal:  Circ Res       Date:  2011-04-15       Impact factor: 17.367

Review 4.  CO(2)/HCO(3)(-)-responsive soluble adenylyl cyclase as a putative metabolic sensor.

Authors:  J H Zippin; L R Levin; J Buck
Journal:  Trends Endocrinol Metab       Date:  2001-10       Impact factor: 12.015

5.  Alteration of vascular reactivity in heart failure: role of phosphodiesterases 3 and 4.

Authors:  F Hubert; M Belacel-Ouari; B Manoury; K Zhai; V Domergue-Dupont; P Mateo; F Joubert; R Fischmeister; V Leblais
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

6.  Calcium-dependent mitochondrial cAMP production enhances aldosterone secretion.

Authors:  Dávid Katona; Anikó Rajki; Giulietta Di Benedetto; Tullio Pozzan; András Spät
Journal:  Mol Cell Endocrinol       Date:  2015-05-06       Impact factor: 4.102

Review 7.  Roles of mitochondria in human disease.

Authors:  Michael R Duchen; Gyorgy Szabadkai
Journal:  Essays Biochem       Date:  2010       Impact factor: 8.000

Review 8.  Microdomains of intracellular Ca2+: molecular determinants and functional consequences.

Authors:  Rosario Rizzuto; Tullio Pozzan
Journal:  Physiol Rev       Date:  2006-01       Impact factor: 37.312

9.  Pharmacological screening and enzymatic assays for apoptosis.

Authors:  Anne-Sophie Belzacq-Casagrande; Cecile Martel; Claire Pertuiset; Annie Borgne-Sanchez; Etienne Jacotot; Catherine Brenner
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

Review 10.  The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury.

Authors:  Andrew P Halestrap; Andrew P Richardson
Journal:  J Mol Cell Cardiol       Date:  2014-08-30       Impact factor: 5.000

View more
  36 in total

1.  Regulation of AMPK activity by type 10 adenylyl cyclase: contribution to the mitochondrial biology, cellular redox and energy homeostasis.

Authors:  Vignesh Jayarajan; Avinash Appukuttan; Muhammad Aslam; Peter Reusch; Vera Regitz-Zagrosek; Yury Ladilov
Journal:  Cell Mol Life Sci       Date:  2019-06-06       Impact factor: 9.261

Review 2.  Mitohormesis and metabolic health: The interplay between ROS, cAMP and sirtuins.

Authors:  Carlos Marques Palmeira; João Soeiro Teodoro; João Alves Amorim; Clemens Steegborn; David A Sinclair; Anabela Pinto Rolo
Journal:  Free Radic Biol Med       Date:  2019-07-24       Impact factor: 7.376

3.  Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model.

Authors:  Belén Mollá; Diana C Muñoz-Lasso; Pablo Calap; Angel Fernandez-Vilata; María de la Iglesia-Vaya; Federico V Pallardó; Maria Dolores Moltó; Francesc Palau; Pilar Gonzalez-Cabo
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

Review 4.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 5.  Melatonin and the electron transport chain.

Authors:  Rüdiger Hardeland
Journal:  Cell Mol Life Sci       Date:  2017-08-07       Impact factor: 9.261

6.  17β-Estradiol reduces mitochondrial cAMP content and cytochrome oxidase activity in a phosphodiesterase 2-dependent manner.

Authors:  Sofya Pozdniakova; Mariona Guitart-Mampel; Gloria Garrabou; Giulietta Di Benedetto; Yury Ladilov; Vera Regitz-Zagrosek
Journal:  Br J Pharmacol       Date:  2018-09-08       Impact factor: 8.739

Review 7.  Mitochondrial cAMP and Ca2+ metabolism in adrenocortical cells.

Authors:  András Spät; Gergő Szanda
Journal:  Pflugers Arch       Date:  2018-06-06       Impact factor: 3.657

8.  Absinthin, an agonist of the bitter taste receptor hTAS2R46, uncovers an ER-to-mitochondria Ca2+-shuttling event.

Authors:  Maria Talmon; Silvia Rossi; Dmitry Lim; Federica Pollastro; Gioele Palattella; Federico A Ruffinatti; Patrizia Marotta; Renzo Boldorini; Armando A Genazzani; Luigia G Fresu
Journal:  J Biol Chem       Date:  2019-06-27       Impact factor: 5.157

9.  Sex differences in gene expression in response to ischemia in the human left ventricular myocardium.

Authors:  Gregory Stone; Ashley Choi; Oliva Meritxell; Joshua Gorham; Mahyar Heydarpour; Christine E Seidman; Jon G Seidman; Sary F Aranki; Simon C Body; Vincent J Carey; Benjamin A Raby; Barbara E Stranger; Jochen D Muehlschlegel
Journal:  Hum Mol Genet       Date:  2019-05-15       Impact factor: 6.150

10.  The functional association between the sodium/bicarbonate cotransporter (NBC) and the soluble adenylyl cyclase (sAC) modulates cardiac contractility.

Authors:  María S Espejo; Alejandro Orlowski; Alejandro M Ibañez; Romina A Di Mattía; Fernanda Carrizo Velásquez; Noelia S Rossetti; María C Ciancio; Verónica C De Giusti; Ernesto A Aiello
Journal:  Pflugers Arch       Date:  2019-11-22       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.